|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating Activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Stock-based compensation expense | ||
| Change in fair value of derivative tranche liability | ||
| Impairment of right-of-use asset | ||
| Loss on the sale of property and equipment | ||
| Non-cash gain on lease modification | ||
| Non-cash lease expense | ||
| Non-cash interest expense | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | ||
| Accounts payable | ||
| Accrued expenses and other liabilities | ||
| Operating lease assets and liabilities | ||
| Deferred revenue | ||
| Net cash used in operating activities | ||
| Investing Activities | ||
| Purchases of property and equipment | ||
| Proceeds from the sale of property and equipment | ||
| Net cash used in investing activities | ||
| Financing Activities | ||
| Proceeds from issuance of common stock, net of issuance costs of $3,966 and $5,747, respectively | ||
| Proceeds from issuance of pre-funded warrants, net of issuance costs $258 | ||
| Proceeds allocated to the derivative tranche liability | ||
| Proceeds from exercise of common stock options | ||
| Principal payments on financing obligation | ||
| Principal payments on finance leases | ||
| Payments of deferred offering costs | ||
| Payments of deferred issuance costs | ||
| Net cash provided by financing activities | ||
| Net increase in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of year | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Operating lease right-of-use asset obtained in exchange for lease liabilities | ||
| Finance lease right-of-use asset obtained in exchange for lease liabilities | ||
| Conversion of convertible preferred stock upon initial public offering | ||
| Finance lease right-of-use asset converted to fixed asset | ||
| Issuance costs in accounts payable and accrued expenses |
Loading...
